01406 CLARITY MEDICAL
Suspend Add to PorfolioKey Financial Ratio (Fiscal Year: 03/2024) | |||
Current | 4.41X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 3.3% | Net Margin | N/A |
Total Debt/Equity | 13.4% | Return on Equity | N/A |
Price/Book | 0.99X | Return on Assets | N/A |
(HKD 0.355) | 2024-03 | 2023-03 | 2022-03 | 2021-03 | 2020-03 |
Net Profit (MHKD) | -75.79 | -3.19 | 13.49 | 35.77 | 26.39 |
---|---|---|---|---|---|
Net Profit Growth (%) | -2,275.2 | -123.7 | -62.3 | +35.6 | -12.2 |
Earnings Per Share (HKD) | -0.144 | -0.006 | 0.035 | 0.095 | 5599.958 |
Earnings Per Share Growth (%) | -2,267.2 | -117.6 | -63.7 | -100.0 | -17.1 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | 10.26 | 3.72 | 0.00 |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.359 | 0.491 | 0.501 | N/A | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2024-09 | 2023-09 | Chg* (%) | 2022-09 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 87.201 | 101.61 | -14.2 | 107.691 |
Operating Result | -17.082 | -23.295 | -26.7 | 10.212 |
Profit Before Taxation | -17.669 | -23.295 | -24.2 | 10.212 |
Taxation | 0.9 | -3.276 | -127.5 | 2.3 |
Profit /( Loss) After Taxation | -18.569 | -20.019 | -7.2 | 7.912 |
Net Profit | -18.569 | -20.019 | -7.2 | 7.912 |
Earnings Per Share () | -0.0351 | -0.0381 | -7.9 | 0.0152 |
Announcement Date | 2024-11-27 | 2023-11-28 | NA | 2022-11-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25